LEVI-04 / Levicept 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LEVI-04 / Levicept
LEVI-04-21-02, NCT05618782 / 2021-006540-28: Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

Active, not recruiting
2
518
Europe, RoW
LEVI-04, Placebo:
Levicept, Nordic Bioscience Clinical Development (NBCD)
Pain, Osteo Arthritis Knee, Knee Osteoarthritis, Arthritis, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases
03/24
07/24

Download Options